Previous studies also claimed that increased Malat1 expression was positively correlated with poor prognosis in pancreatic cancer and PCa (Ren et al., 2013; Chang et al., 2018a; Goyal et al., 2021). This evidence concerns the gene MALAT1 and familial pancreatic carcinoma.